Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

708 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenarios.
Hardcastle N, Vasquez Osorio E, Jackson A, Mayo C, Aarberg AE, Ayadi M, Belosi F, Ceylan C, Davey A, Dupuis P, Handley JC, Hemminger T, Hoffmann L, Kelly C, Michailidou C, Muscat S, Murrell DH, Pérez-Alija J, Palmer C, Placidi L, Popovic M, Rønde HS, Selby A, Skopidou T, Solomou N, Stroom J, Thompson C, West NS, Zaila A, Appelt AL. Hardcastle N, et al. Among authors: hoffmann l. Radiother Oncol. 2024 May;194:110184. doi: 10.1016/j.radonc.2024.110184. Epub 2024 Mar 5. Radiother Oncol. 2024. PMID: 38453055 Free article.
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study.
Møller DS, Nielsen TB, Brink C, Hoffmann L, Lutz CM, Drøgemüller Lund M, Hansen O, Schytte T, Khalil AA, Knap MM, Nyhus CH, Ottosson W, Sibolt P, Borissova S, Josipovic M, Persson G, Appelt AL. Møller DS, et al. Among authors: hoffmann l. Radiother Oncol. 2017 Aug;124(2):311-317. doi: 10.1016/j.radonc.2017.06.022. Epub 2017 Jul 5. Radiother Oncol. 2017. PMID: 28688525 Free article. Clinical Trial.
Early radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC.
Tvilum M, Knap MM, Hoffmann L, Khalil AA, Appelt AL, Haraldsen A, Alber M, Grau C, Schmidt HH, Kandi M, Holt MI, Lutz CM, Møller DS. Tvilum M, et al. Among authors: hoffmann l. Clin Transl Radiat Oncol. 2024 Jan 23;45:100737. doi: 10.1016/j.ctro.2024.100737. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2024. PMID: 38317680 Free PMC article.
Different benefits of adaptive radiotherapy for different histologies of NSCLC.
Tvilum M, Lutz CM, Knap MM, Hoffmann L, Khalil AA, Holt MI, Kandi M, Schmidt HH, Appelt AL, Alber M, Møller DS. Tvilum M, et al. Among authors: hoffmann l. Acta Oncol. 2023 Nov;62(11):1426-1432. doi: 10.1080/0284186X.2023.2260944. Epub 2023 Nov 7. Acta Oncol. 2023. PMID: 37796133
Radiation dose to heart and cardiac substructures and risk of coronary artery disease in early breast cancer patients: A DBCG study based on modern radiation therapy techniques.
Holm Milo ML, Slot Møller D, Bisballe Nyeng T, Hoffmann L, Dahl Nissen H, Jensen I, Laugaard Lorenzen E, Bech Jellesmark Thorsen L, Melgaard Nielsen K, Paaske Johnsen S, Brink Valentin J, Alsner J, Vrou Offersen B. Holm Milo ML, et al. Among authors: hoffmann l. Radiother Oncol. 2023 Mar;180:109453. doi: 10.1016/j.radonc.2022.109453. Epub 2023 Jan 13. Radiother Oncol. 2023. PMID: 36642388
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer.
Thomas M, Mortensen HR, Hoffmann L, Møller DS, Troost EGC, Muijs CT, Berbee M, Bütof R, Nicholas O, Radhakrishna G, Defraene G, Nafteux P, Nordsmark M, Haustermans K. Thomas M, et al. Among authors: hoffmann l. Radiother Oncol. 2021 Mar;156:102-112. doi: 10.1016/j.radonc.2020.11.032. Epub 2020 Dec 5. Radiother Oncol. 2021. PMID: 33285194
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres.
Hoffmann L, Mortensen H, Shamshad M, Berbee M, Bizzocchi N, Bütof R, Canters R, Defraene G, Ehmsen ML, Fiorini F, Haustermans K, Hulley R, Korevaar EW, Clarke M, Makocki S, Muijs CT, Murray L, Nicholas O, Nordsmark M, Radhakrishna G, Thomas M, Troost EGC, Vilches-Freixas G, Visser S, Weber DC, Møller DS. Hoffmann L, et al. Radiother Oncol. 2022 Jul;172:32-41. doi: 10.1016/j.radonc.2022.04.029. Epub 2022 May 2. Radiother Oncol. 2022. PMID: 35513132 Free article. Clinical Trial.
708 results